Stem cell exosome injection for early hip necrosis
This study tests a new treatment using stem cell exosomes injected into the hip joint for people with early-stage non-traumatic avascular necrosis of the femoral head (a condition where bone tissue in the hip dies due to poor blood supply, not caused by injury). The goal is to see if it is safe and may help improve hip function and pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must have non-traumatic avascular necrosis of the femoral head at Stage II or IIIA (early stage).
- Your affected hip must not have received any prior surgical or injection treatment.
- You must not have an active infection, autoimmune disease, or immunodeficiency.
- You must not have a history of cancer, severe heart failure, or uncontrolled high blood pressure or diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether injecting your own bone marrow into the hip can help heal early-stage osteonecrosis (bone death) before the bone collapses. It is for people who have not had prior hip surgery and do not have certain conditions like sickle cell disease.
This study is testing a new way to repair the damaged bone in your hip by using your own bone marrow stem cells. You may be a candidate if you have femoral head necrosis (hip bone death) that did not get better with standard treatments and you are otherwise healthy enough for surgery.
This trial studies whether a natural substance called exosomes, derived from stem cells, can help reduce pain and improve function in people with knee osteoarthritis. It may be an option if other treatments have not worked well for you.
This trial tests an “autologous” regenerative cell treatment, meaning cells taken from you, to reduce hip osteoarthritis pain and inflammation. It checks safety first and looks for improvements in how you feel and move.
This early-phase study tests an injection of donor stem cells placed into the knee joint to help reduce symptoms of knee osteoarthritis. You may be eligible if you have long-lasting knee pain from mild-to-moderate arthritis and meet safety and imaging requirements.
This Phase 2 study tests whether stem cell injections can reduce pain and improve symptoms in people with knee or hip osteoarthritis. You may be considered if you have moderate-to-severe pain despite trying standard treatments.
Hear when a new Non Traumatic Osteonecrosis of the Femoral Head (Hip) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.